Background GLP-1R agonists protect the blood-brain barrier (BBB): These drugs help maintain the integrity of the BBB by preventing tight junction degradation, which can reduce the risk of neuroinflammation and cognitive decline
Some of the most compelling research: One study, published in July 2026 in BMJ Open , compared the effects of GLP-1s with approved AUD drugs
You probably know that GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) have transformed how we treat obesity
Commonly Prescribed GLP-1 Medications Two of the most widely prescribed GLP-1 receptor agonists are Ozempic and Wegovy
In contrast, Noom states that their dosing starts at 25% or less of the standard 0.25 mg dose and escalates at a personalized rate. While microdosing GLP-1 medications may provide a more personalized experience, there are still questions regarding the safety of this practice as there are currently no published studies on the process, and the microdoses may come from a compounding pharmacy
Comprehensive review on alzheimers disease: Causes and treatment
